Supplementary Figure S3 from DNA-Methylome based Tumor Hypoxia Classifier Identifies HPV-negative Head & Neck Cancer Patients at Risk for Locoregional Recurrence After Primary Radiochemotherapy

Bouchra Tawk; Katrin Rein; Christian Schwager; Maximilian Knoll; Ute Wirkner; Juliane Hörner‐Rieber; Jakob Liermann; Ina Kurth; Panagiotis Balermpas; Claus Roedel; Annett Linge; Steffen Loeck; Fabian Lohaus; Ingeborg Tinhofer; Mechthild Krause; Martin Stuschke; Anca‐Ligia Grosu; Daniel Zips; Stephanie E. Combs; Claus Belka; Albrecht Stenzinger; Christel Herold‐Mende; Michaël Baumann; Peter Schirmacher; Jürgen Debus; Amir Abdollahi

doi:10.1158/1078-0432.27030940.v1

Abstract

Supplementary Figure S3. (Top) Hypoxia-M V2 is associated with decreased OS in the TCGApancancer cohort (p<0.002) (Bottom) Hypoxia-M V2 is an independent prognosticator of OS (HR=1.81, p<0.03) after adjusting for demographic and clinical factors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tawk et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522f1b https://doi.org/10.1158/1078-0432.27030940.v1

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S3 from DNA-Methylome based Tumor Hypoxia Classifier Identifies HPV-negative Head & Neck Cancer Patients at Risk for Locoregional Recurrence After Primary Radiochemotherapy

Abstract

Discussion

Cite This Study

Supplementary Figure S3 from DNA-Methylome based Tumor Hypoxia Classifier Identifies HPV-negative Head & Neck Cancer Patients at Risk for Locoregional Recurrence After Primary Radiochemotherapy

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers